Related Experiment Video
Updated: Jan 17, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Antihypertensive Medication as a Risk Factor For Basal Cell Carcinoma: A Nationwide Registry-based Case-control Study
Johan Kappelin1, Ingela Ahnlide2, Gustav B Christensen3
1Lund University Skin Cancer Research Group, Department of Clinical Sciences Lund, Dermatology, Lund University, Sweden; Department of Dermatology, Skåne University Hospital, Landskrona, Sweden. johan.kappelin@med.lu.se.
Commonly prescribed blood pressure drugs like thiazides (in combination), ARBs, CCBs, and beta-blockers are linked to higher basal cell carcinoma (BCC) risk. Single-agent thiazide use showed no increased risk.
Area of Science:
- Dermatology
- Pharmacology
- Epidemiology
Background:
- Hydrochlorothiazide is linked to squamous cell carcinoma but its association with basal cell carcinoma (BCC) is debated.
- Antihypertensive medications are widely prescribed, necessitating investigation into their potential BCC risks.
Purpose of the Study:
- To investigate the association between commonly prescribed antihypertensive medications and the risk of developing basal cell carcinoma (BCC).
Main Methods:
- A nationwide, registry-based, case-control study in Sweden (2007-2017).
- Included 133,539 BCC cases and 257,849 matched controls.
- Analyzed data on antihypertensive prescriptions, comorbidities, and socioeconomic factors.
Main Results:
- Thiazide-containing combination treatments (OR 1.09), angiotensin II receptor blockers (OR 1.09), calcium channel blockers (OR 1.09), and beta-blockers (OR 1.07) were associated with increased BCC risk.
- Single-agent thiazide treatment did not show an increased BCC risk.
- Combination thiazide therapy increased BCC risk, suggesting further study of adjunctive substances.
Conclusions:
- Several common antihypertensives are significantly associated with an increased risk of basal cell carcinoma (BCC).
- Thiazide's effect on BCC risk appears dependent on combination therapy.
- Current recommendations emphasize UV protection over altering antihypertensive regimens for BCC prevention.
More Related Videos
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension and Regulation of Blood Pressure

